Sign in
4

Changes in Ownership

AEON Biopharma, Inc. Filed Acc 0001104659-23-083570

Options or other derivatives

  • CLO and Corporate Secretary acquired 278,340 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wilson Alexander Blair · CLO and Corporate Secretary

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2023-07-21 Grant or award : show line 1 in the form Stock Option +77,647 77,647 D
2023-07-21 Grant or award : show line 2 in the form Stock Option +12,656 12,656 D
2023-07-21 Grant or award : show line 3 in the form Stock Option +106,609 106,609 D
2023-07-21 Grant or award : show line 4 in the form Restricted Stock Units +81,428 81,428 D
Loading xslF345X05/tm2321918-12_4seq1.xml…